U.S., May 28 -- ClinicalTrials.gov registry received information related to the study (NCT07608562) titled 'Azithromycin for Cerclage Prophylaxis' on May 20.
Brief Summary: The primary goal is to assess the effectiveness in pregnancy prolongation utilizing azithromycin at the time of transvaginal cervical cerclage placement.
Study Start Date: June, 2026
Study Type: INTERVENTIONAL
Condition:
Cervical Insufficiency
Intervention:
DRUG: Azithromycin Prophylaxis
500 mg of IV azithromycin prior to cerclage placement in the operating room or pre-operative area.
DRUG: Azithromycin Placebo
normal saline placebo IV infusion prior to cerclage placement in the operating room or pre-operative area
DRUG: Cefazolin
All participants will receiv...